Literature DB >> 11326488

Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis.

C Modesto1, P Woo, J García-Consuegra, R Merino, M García-Granero, C Arnal, A M Prieur.   

Abstract

OBJECTIVE: To explore all the common clinical and biological variables that are characteristic of Systemic onset Juvenile Chronic Arthritis (SoJCA) in order to determine which of them are suitable as predictors of a bad articular outcome (persistence of inflammatory symptoms and/or established limitation of the range of motion (ROM).
MATERIAL AND METHODS: Clinical charts for 124 SoJCA patients were retrospectively reviewed. From them, 91 were finally included in the study because they had all of the clinical and biological data at disease onset properly recorded. All have been followed for at least 3 years since the beginning of the disease. Data collected at onset, and after 3 and 6 months of the disease included: 1) systemic symptoms; 2) joint involvement, using both the usual articular count and the value of an articular index (Helsinki Index = HI) which intentionally excludes those joints that are not uniformly recorded in clinical charts; and 3) biological data. HI was used to separate the patients into two groups. When applied 3 years after the disease onset, HI > or = 10 represented a bad articular outcome while HI < 10 meant a good prognosis. SPSS for Windows 6.1 was used for both the univariate and multivariate analyses.
RESULTS: From the multivariate logistic regression analysis, two different "clusters" of clinical data were found to be the best predictors of a bad articular outcome. A bad prognosis was linked at onset with the presence of generalized lymphadenopathies, age < 8 years and an HI > 6; at six months a bad outcome was linked with the presence of a polyarticular pattern plus hip involvement.
CONCLUSION: Clinical parameters at the beginning of the disease were shown to be extremely useful in predicting the articular outcome of SoJCA. Therefore, they could constitute a good instrument to help clinicians tailor the best therapy for their patients.

Entities:  

Mesh:

Year:  2001        PMID: 11326488

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  13 in total

1.  Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis.

Authors:  Hatice Ezgi Baris; Edwin Anderson; Betul Sozeri; Fatma Dedeoglu
Journal:  Clin Rheumatol       Date:  2018-09-20       Impact factor: 2.980

Review 2.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Authors:  Timothy Beukelman; Nivedita M Patkar; Kenneth G Saag; Sue Tolleson-Rinehart; Randy Q Cron; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Alberto Martini; C Egla Rabinovich; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

3.  Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis.

Authors:  Xuefeng B Ling; Kenneth Lau; Chetan Deshpande; Jane L Park; Diana Milojevic; Claudia Macaubas; Chris Xiao; Viorica Lopez-Avila; John Kanegaye; Jane C Burns; Harvey Cohen; James Schilling; Elizabeth D Mellins
Journal:  Clin Proteomics       Date:  2010-09-30       Impact factor: 3.988

4.  Hip involvement in juvenile idiopathic arthritis.

Authors:  S Rostom; B Amine; R Bensabbah; R Abouqal; N Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2008-02-15       Impact factor: 2.980

Review 5.  Prognostic factors in juvenile idiopathic arthritis.

Authors:  A M Prieur; G Chèdeville
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.686

6.  Clinical, laboratory, and ultrasound assessment of the knee in juvenile rheumatoid arthritis.

Authors:  Shereen Algergawy; Tohamy Haliem; Osama Al-Shaer
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2011-04-25

7.  Associations of IL-4, IL-4R, and IL-13 gene polymorphisms in coal workers' pneumoconiosis in China: a case-control study.

Authors:  Meilin Wang; Shasha Wang; Zhifang Song; Xiaomin Ji; Zhengdong Zhang; Jianwei Zhou; Chunhui Ni
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

8.  Systemic arthritis in children: a review of clinical presentation and treatment.

Authors:  R Gurion; T J A Lehman; L N Moorthy
Journal:  Int J Inflam       Date:  2011-12-25

9.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.

Authors:  Virginia Pascual; Florence Allantaz; Edsel Arce; Marilynn Punaro; Jacques Banchereau
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

10.  Application of the Yamaguchi criteria for classification of "suspected" systemic juvenile idiopathic arthritis (sJIA).

Authors:  Sharath Kumar; Divya Shree Kunhiraman; Lalitha Rajam
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-23       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.